| Patents for C07K - Peptides (3,738) |
|---|
| 08/25/2004 | CN1163265C Pharmaceutical formulations of nerve growth factor |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/19/2004 | WO2004069860A2 Isg15-conjugated proteins |
| 08/19/2004 | WO2004069176A2 Polymer conjugates of mutated neublastin |
| 08/19/2004 | WO2004056846A3 Special film-coated substrate for bio-microarray fabrication and use thereof |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | CA2514510A1 Polymer conjugates of mutated neublastin |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004067551A2 Method for identifying peptides by mass spectrometry |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004046166A3 Modified alpha-msh peptides and derivatives thereof |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2485568A1 Variant integrin polypeptides and uses thereof |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/05/2004 | WO2004065409A2 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines |
| 08/05/2004 | WO2004065408A2 Enhancement of humoral immune responses using a novel myeloid accessory cell |
| 08/05/2004 | WO2004065406A2 Rantes-derived peptides with anti-hiv activity |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040151722 Treatment of metabolic disorders using TNFalpha inhibitors |
| 07/29/2004 | WO2003033644A3 Peptide useful in immunomodulation |
| 07/29/2004 | US20040146991 Identifying modulator of activation inducible lymphocyte immunomodulatory molecule (AILIM) for use in suppressing, preventing and/or treating inflammatory, autoimmune and allergic disorders |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/27/2004 | US6767994 Used in purification of apolipoprotein a (apoa) or apolipoprotein e; apoa or apoe produced by the process can be used for the manufacture of a medicament in the treatment of atherosclerosis and cardiovascular diseases |
| 07/22/2004 | WO2004060912A2 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes |
| 07/22/2004 | WO2004033485A3 Nucleic acid supported protein complementation |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | US20040142355 Methods, compositions and libraries pertaining to PNA dimer and PNA oligomer synthesis |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/15/2004 | WO2004058801A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | WO2004058799A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 07/15/2004 | WO2004058798A2 Antimicrobial peptides |
| 07/15/2004 | WO2004043991A3 Assay for tissue factor and factor viia |
| 07/15/2004 | US20040138136 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137469 Peptide Nucleic Acids (PNA); an acid forming cleavable linker and a PNA dimer comprising an N-terminal base labile protecting group, cleavably linked to the solid support through the cleavable linker |
| 07/15/2004 | US20040137426 Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cells |
| 07/15/2004 | US20040136991 Treatment of anemia using TNFalpha inhibitors |
| 07/15/2004 | US20040136990 Treatment of pain using TNFalpha inhibitors |
| 07/15/2004 | US20040136989 Kawasaki's Disease; Behcet's disease; TNF alpha antibody, or an antigen-binding fragment |
| 07/15/2004 | CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/08/2004 | WO2004056846A2 Special film-coated substrate for bio-microarray fabrication and use thereof |
| 07/08/2004 | US20040131614 Treatment of pulmonary disorders using TNFalpha inhibitor |
| 07/01/2004 | WO2004055041A2 Defensin-inducing peptides from fusobacterium |
| 07/01/2004 | WO2003097666A3 Use of gastrin releasing peptide (grp) and its receptor in cancer screening |
| 07/01/2004 | US20040127423 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040127408 based on the complementarity-determining region (CDR) of a human monoclonal anti-DNA antibody |
| 07/01/2004 | US20040127399 complex consisting of a divalent metal cation associated with and capable of co-precipitating with such a peptide for enhancing the expression of insulin from mammalian pancreatic B-type islet cells |
| 07/01/2004 | US20040126421 formed from peptide having ubiquitinatable region and antigenic region (with leukemia-/sarcoma- associated oncofusion protein breakpoint region), pH-sensitive liposomal carrier and bilayer-associated adjuvant; vaccines |
| 07/01/2004 | US20040126373 Administering tumor necrosis factor antibody; restenosis |
| 07/01/2004 | US20040126372 Administering antibodies; respiratory system disorders; cardiovascular disorders; metabolism disorders; anemia; analgesics; liver disorders; skin disorders |
| 06/24/2004 | WO2004052919A2 Peptide deformylase inhibitors |
| 06/24/2004 | WO2004052918A2 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 06/24/2004 | WO2004052916A2 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids |
| 06/24/2004 | US20040121953 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 06/24/2004 | US20040121339 comprises a surface coated with a polyelectrolyte-silica or alternating polycationic and polyanionic polymers; can immobilize biological matters by electrostatic and porous adsorptions and potentially hydrogen bonds as well |
| 06/23/2004 | CN1154725C Human bikunin |
| 06/23/2004 | CN1154657C Cyclic peptide analogs of somatostatin |
| 06/17/2004 | WO2004050684A2 Methods for improving secondary metabolite production in fungi |
| 06/17/2004 | WO2004050681A2 Kinase modulators |
| 06/17/2004 | WO2004050679A2 Mutant glycoproteins |
| 06/17/2004 | CA2508544A1 Methods for improving secondary metabolite production in fungi |
| 06/17/2004 | CA2506546A1 Kinase modulators |
| 06/17/2004 | CA2469724A1 Mutant glycoproteins |
| 06/16/2004 | EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/10/2004 | WO2004048399A2 Skin or hair binding peptides |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/03/2004 | WO2004046365A2 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | WO2004046168A2 Recombinant hiv-1 subclass d envelope glycoproteins |
| 06/03/2004 | WO2004046167A2 Synthesis and self-assembly of abc triblock bola peptide |
| 06/03/2004 | WO2004046166A2 Modified alpha-msh peptides and derivatives thereof |
| 06/03/2004 | US20040106554 polypeptide analogs of myelin basic protein for treatment of multiple sclerosis |
| 06/03/2004 | US20040106547 glucose lowering protein (GLP-1); exendins; for regulation of excess levels of blood glucose and/or regulation of gastric emptying; for treatment of diabetes and eating disorders |
| 06/03/2004 | US20040105868 HCV epitopes vaccines for immunization for Hepatitis C polypeptides for CD antigens |
| 06/03/2004 | CA2504267A1 Interferon-alpha polypeptides and conjugates |
| 05/27/2004 | WO2004043991A2 Assay for tissue factor and factor viia |
| 05/27/2004 | WO2004043988A2 Ptprk immunogenic peptide |
| 05/26/2004 | EP1421379A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/21/2004 | WO2004041846A2 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES |
| 05/21/2004 | WO2004041845A2 Templated native silk smectic gels |
| 05/21/2004 | WO2004041844A2 Cell cycle targets and peptides |
| 05/21/2004 | WO2004041842A2 Epitopes of hepatitis c virus |
| 05/21/2004 | CA2504125A1 Inducible ligand for .alpha.1.beta.1 integrin and uses |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/06/2004 | WO2004037852A2 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 05/06/2004 | WO2004037847A2 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |